Hepion Pharmaceuticals, Inc. (HEPA): Net Income
-$8.28M
Year ended 2025-12-31
-$3.19M
Trailing 12 months to 2026-06-30
| Period ended | Net Income | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | -$8.28M | n/m | 2026-03-12, From 2025-01-01 |
| 2024-12-31 | -$13.19M | n/m | 2026-03-12, From 2024-01-01 |
| 2023-12-31 | -$48.93M | n/m | 2025-04-08, From 2023-01-01 |
| 2022-12-31 | -$42.20M | n/m | 2024-04-16, From 2022-01-01 |
| 2021-12-31 | -$32.72M | n/m | 2023-04-10, From 2021-01-01 |
| 2020-12-31 | -$20.35M | n/m | 2022-04-08, From 2020-01-01 |
| 2019-12-31 | -$7.04M | n/c | 2021-03-31, From 2019-01-01 |
| 2018-12-31 | -$9.45M | n/a | 2020-05-14, From 2018-01-01 |
| No annual figure between 2017-06-30 and 2018-12-31. | |||
| 2017-06-30 | -$14.89M | n/m | 2019-03-14, From 2016-07-01 |
| 2016-06-30 | -$17.00M | n/m | 2017-09-28, From 2015-07-01 |
| 2015-06-30 | -$14.35M | n/m | 2016-09-28, From 2014-07-01 |
| 2014-06-30 | -$5.28M | n/a | 2015-09-25, From 2013-07-01 |
Net Income at similar companies
| Company | Year ended | Net Income | Change YoY |
|---|---|---|---|
| Hepion Pharmaceuticals, Inc. (HEPA) | 2025-12-31 | -$8.28M | n/m |
| InMed Pharmaceuticals Inc. (INM) | 2026-06-30 | -$12.56M | n/m |
| Alaunos Therapeutics, Inc. (TCRT) | 2025-12-31 | -$4.18M | n/m |
| Avenue Therapeutics, Inc. (ATXI) | 2025-12-31 | -$2.91M | n/m |
| Neonc Technologies Holdings, Inc. (NTHI) | 2025-12-31 | -$62.15M | n/m |
| BullFrog AI Holdings, Inc. (BFRG) | 2025-12-31 | -$6.50M | n/m |
| Artelo Biosciences, Inc. (ARTL) | 2025-12-31 | -$12.88M | n/m |
| Lipella Pharmaceuticals Inc. (LIPO) | 2024-12-31 | -$5.02M | n/m |
| Vaccinex, Inc. (VCNX) | 2024-12-31 | -$18.63M | n/m |
Compare HEPA, INM, TCRT, ATXI side by side · Screen every company in Pharmaceutical Preparations ↗